Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia

Background Additional chromosomal aberrations in Philadelphia chromosome-positive chronic myeloid leukemia are non-random and strongly associated with disease progression, but their prognostic impact and effect on treatment response is not clear. Point mutations in the BCR-ABL kinase domain are prob...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Theo D. Kim, Seval Türkmen, Michaela Schwarz, Gökben Koca, Hendrik Nogai, Christiane Bommer, Bernd Dörken, Peter Daniel, Philipp le Coutre
Format:	Artigo
Jezik:	Inglês
Izdano:	Ferrata Storti Foundation 2010-04-01
Serija:	Haematologica
Online dostop:	https://haematologica.org/article/view/5554
Oznake:	Označite Brez oznak, prvi označite!